It is our pleasure to invite you to the 3rd International XLH Symposium hosted by the International XLH Alliance to be held on July 1st 2022 in Dublin, Ireland.

This Symposium will bring together scientists and clinicians from a wide range of disciplines to gain a better understanding of x-linked hypophosphataemia and offer the latest in research and treatment management.

We invite anyone with an interest in XLH in paedriatrics, adolescents and adult care to attend.

The scientific programme is designed to present researchers, physicians, and allied health professionals with the newest research, with sessions by world-leading experts.

The Symposium is organised in association with the 10th International Conference on Children’s Bone Health (ICCBH) in Dublin, 2-5 July. Details at https://www.iccbh.org/

Scientific Programme





O’Brien Centre for Science. George Moore. University College Dublin (UCD). Dublin, Ireland.


Date and Time

July 1st 2022, 11:00 – 18:30


Recommendations coming soon…

Programme Organising Committee

Agnès Linglart (France)
Artemis Doulgeraki (Greece)
Dieter Haffner (Germany)
Elizabeth Olear (USA)
Karl Insogna (USA)
Oliver Gardiner (UK)
Pol Harvengt (Belgium)
Tenna Toft Sylvest (Denmark)
Thomas Carpenter (USA)

Medical Advisory Board

Coming soon…

The History of the XLH Symposium


Organized by Prof. Agnès Linglart from Hôpital Bicêtre, Prof. Catherine Chaussain from Université Paris Descartes and RVRH, the patient association in France jointly organised the first XLH Symposium held on September 9th 2016 in Paris at the the Imagine Institute. The symposium was attended by more than 130 doctors and researchers from 23 countries.


2018-Symposium-athensOn September 26th 2018, RVRH organised the 2nd XLH Symposium at the Aigli Zappeion in Athens, Greece. It took place just one day before the 57th annual ESPE meeting. The symposium brought together experts, patients and parents from across the globe to discuss all aspects of XLH; pathophysiology and current research, clinical manifestations, challenging cases and treatment throughout the lifespan.

share on